Literature DB >> 22392157

Measuring adherence to antiretroviral treatment: the role of pharmacy records of drug withdrawals.

Eliana Battaggia Gutierrez1, Ana Marli Christovam Sartori, Ana Lucia Schmidt, Bruna Mamprim Piloto, Bruna Biagi França, Adriana Santos de Oliveira, Adriana Rodrigues Pouza, Roberta Vilela Moreno, Camila de Melo Picone, Manoel Carlos Sampaio de Almeida Ribeiro.   

Abstract

This study aimed to evaluate adherence to antiretroviral treatment (ART) among HIV + adults, assess its association with HIV viral load (VL) and identify factors associated to adherence. A survey involving a random sample of adults followed at a HIV/AIDS reference center in São Paulo city, Brazil, from 2007 to 2009 was done. A questionnaire was applied and data were retrieved from the pharmacy and medical records. The study involved 292 subjects: 70.2% men; median age: 43 years; median duration of ART: 8 years. 89.3% self-reported taken all prescribed pills in the last 3 days but only 39.3% picked up ≥95% of the prescribed ART from the pharmacy in the last 12 months. At the multivariate analysis having symptoms prior to ART, taking fewer ART pills, and not missing medical appointments were independently associated to higher adherence. Adherence was strongly associated with undetectable HIV VL. Rates of undetectable HIV VL did not differ from 80 to ≥95% of adherence.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22392157     DOI: 10.1007/s10461-012-0168-3

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  7 in total

1.  Short Communication: Bioequivalence of Tenofovir and Emtricitabine After Coencapsulation with the Proteus Ingestible Sensor.

Authors:  Mustafa E Ibrahim; Kristina M Brooks; José R Castillo-Mancilla; Cricket McHugh; Mary Morrow; Jennifer Brothers; Samantha MaWhinney; Sybil Hosek; Gregory Huhn; Peter L Anderson
Journal:  AIDS Res Hum Retroviruses       Date:  2018-09-05       Impact factor: 2.205

2.  Characteristics of HIV patients who missed their scheduled appointments.

Authors:  Delsa Nagata; Eliana Battaggia Gutierrez
Journal:  Rev Saude Publica       Date:  2015-12-31       Impact factor: 2.106

3.  Adherence to antiretroviral therapy for HIV/AIDS in Latin America and the Caribbean: Systematic review and meta-analysis.

Authors:  Jessica de Mattos Costa; Thiago Silva Torres; Lara Esteves Coelho; Paula Mendes Luz
Journal:  J Int AIDS Soc       Date:  2018-01       Impact factor: 5.396

4.  Monitoring self-reported adherence to antiretroviral therapy in public HIV care facilities in Brazil: A national cross-sectional study.

Authors:  Maria Altenfelder Santos; Mark Drew Crosland Guimarães; Ernani Tiaraju Santa Helena; Cáritas Relva Basso; Felipe Campos Vale; Wania Maria do Espírito Santo Carvalho; Ana Maroso Alves; Gustavo Machado Rocha; Francisco de Assis Acurcio; Maria das Graças Braga Ceccato; Rogério Ruscitto do Prado; Paulo Rossi Menezes; Maria Ines Batistella Nemes
Journal:  Medicine (Baltimore)       Date:  2018-05       Impact factor: 1.889

5.  Pharmacy refill adherence outperforms self-reported methods in predicting HIV therapy outcome in resource-limited settings.

Authors:  Raphael Z Sangeda; Fausta Mosha; Mattia Prosperi; Said Aboud; Jurgen Vercauteren; Ricardo J Camacho; Eligius F Lyamuya; Eric Van Wijngaerden; Anne-Mieke Vandamme
Journal:  BMC Public Health       Date:  2014-10-04       Impact factor: 3.295

6.  Survival benefits of antiretroviral therapy in Brazil: a model-based analysis.

Authors:  Paula M Luz; Michael P Girouard; Beatriz Grinsztejn; Kenneth A Freedberg; Valdilea G Veloso; Elena Losina; Claudio J Struchiner; Rachel L MacLean; Robert A Parker; A David Paltiel; Rochelle P Walensky
Journal:  J Int AIDS Soc       Date:  2016-03-29       Impact factor: 5.396

7.  Hepatitis B viremia in HIV-coinfected individuals under antiretroviral therapy.

Authors:  Leonardo Weissmann; Camila de Melo Picone; Michele Soares Gomes Gouvêa; Paulo Roberto Abrão Ferreira; Mônica Salum Valverde Borsoi Viana; João Renato Rebello Pinho; Alex Jones Flores Cassenote; Aluísio Cotrim Segurado
Journal:  Braz J Infect Dis       Date:  2019-11-09       Impact factor: 3.257

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.